Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae–Induced Rash and Mucositis Concept

The term Mycoplasma pneumoniae–induced rash and mucositis (MIRM) was recently proposed to identify the mucocutaneous condition secondary to M. pneumoniae infection that had historically been regarded among the more confusing pathologies of erythema multiforme and Stevens–Johnson syndrome. Based on a number of previous reports, these syndromes require differentiation since they have different prognoses and specific treatment requirements. We report a case of oral and genital erosions that strongly resembled MIRM without rash but were found to be secondary to a Chlamydia pneumoniae infection. After a thorough review of the literature on this subject, we propose that C. pneumoniae should also be considered a potential causative agent of MIRM and that this term should be amended to include C. pneumoniae infection.

[1]  J. Sarowska,et al.  [Selected aspects of Chlamydophila pneumoniae infections]. , 2015, Postepy higieny i medycyny doswiadczalnej.

[2]  T. Sawada,et al.  Erythema multiforme associated with Chlamydophila pneumoniae infection: a report of two cases and a mini‐literature review , 2015, The Journal of dermatology.

[3]  I. Frieden,et al.  Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. , 2015, Journal of the American Academy of Dermatology.

[4]  L. M. Gomez Mendez,et al.  Stevens-Johnson syndrome, mucositis, or something else? , 2014, Hospital pediatrics.

[5]  S. Imashuku,et al.  Chlamydia Pneumoniae Infection-Associated Erythema Multiforme , 2013, Pediatric reports.

[6]  R. Takahashi,et al.  Adult case of Stevens–Johnson syndrome possibly induced by Chlamydophila pneumoniae infection with severe involvement of bronchial epithelium resulting in constructive respiratory disorder , 2013, The Journal of dermatology.

[7]  S. Lautenschlager,et al.  Mycoplasma pneumoniae and mucositis – part of the Stevens‐Johnson syndrome spectrum , 2012, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[8]  Takashi Kobayashi,et al.  Two cases of erythema exsudativum multiforme associated with Chlamydia pneumoniae infection , 2012, The Journal of dermatology.

[9]  S. How,et al.  The use of multiplex real-time PCR improves the detection of the bacterial etiology of community acquired pneumonia. , 2011, Tropical biomedicine.

[10]  M. Sommerlund,et al.  Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream , 2010, Dermatology reports.

[11]  M. Cruz,et al.  Stevens-Johnson syndrome/erythema multiforme major and Chlamydia pneumoniae infection in young patients , 2010, Dermatology reports.

[12]  F. Blasi,et al.  Chlamydophila pneumoniae. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  J. Dinulos,et al.  Mycoplasma pneumoniae‐induced cutaneous disease , 2009, International journal of dermatology.

[14]  T. Gutteberg,et al.  Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  K. Koelle.  The impact of climate on the disease dynamics of cholera. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  Pierre Vabres,et al.  Érythème polymorphe majeur et infection à Chlamydia pneumoniae , 2006 .

[17]  L. Naldi,et al.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. , 2002, Archives of dermatology.

[18]  R. Peeling,et al.  Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Paavonen,et al.  The use of serologic tests for the diagnosis of chlamydial infections. , 2000, Journal of microbiological methods.

[20]  A. Matsumoto,et al.  [Double infection of Chlamydia pneumoniae and Mycoplasma pneumoniae in children]. , 1996, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[21]  T. Quinn,et al.  Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients , 1994, Journal of clinical microbiology.

[22]  G. Cassell,et al.  Interactions of mycoplasmas with B cells: antibody production and nonspecific effects. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  O. Correia,et al.  Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. , 1993, Archives of dermatology.

[24]  R. Stern,et al.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. , 1993, Archives of dermatology.

[25]  D. Umapathy,et al.  Erythema multiforme in a mother and daughter after M. pneutnoniae infection; a coincidence? , 1987, The British journal of dermatology.

[26]  B. A. Thomas.  So-called Stevens—Johnson Syndrome , 1950, British medical journal.